MediciNova Inc (MNOV) stock
MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.34+0.00 (0.00%)
Close on Nov 17, 2026Market cap $65.96MP/E –Yield –
MediciNova profit margin
Profit margin (net margin) is net income as a percentage of revenue.
MediciNova's profit margin for the twelve months ending Jun 30, 2026 was -1168.2%. For fiscal 2025 it was -2928.8%, against -857.2% the year before. The highest annual figure on record is -251.0% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2928.8% | −2071.6 |
| FY2023 | Dec 31, 2023 | -857.2% | −606.1 |
| FY2021 | Dec 31, 2021 | -251.0% | +123437.3 |
| FY2013 | Dec 31, 2013 | -123688.3% | −122322.5 |
| FY2012 | Dec 31, 2012 | -1365.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -504.8% | +1933.0 |
| Q1 FY2026 | Mar 31, 2026 | -1383.1% | −1310.8 |
| Q4 FY2025 | Dec 31, 2025 | -1846.8% | +7697.7 |
| Q3 FY2025 | Sep 30, 2025 | -2473.6% | −2468.9 |
| Q2 FY2025 | Jun 30, 2025 | -2437.7% | – |
| Q3 FY2023 | Sep 30, 2023 | -72.3% | – |
| Q3 FY2021 | Sep 30, 2021 | -9544.4% | – |
| Q1 FY2021 | Mar 31, 2021 | -4.7% | – |
See a number that looks wrong?